AI assistant
INSMED Inc — Director's Dealing 2020
Jan 6, 2020
30150_dirs_2020-01-06_c8f9ab08-3793-49ae-9c22-bfc83fed1259.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-01-02
Reporting Person: Flammer Martina M.D. (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-02 | Stock Option (right to buy) | $23.66 | A | 150990 | Acquired | 2030-01-02 | Common Stock (150990) | Direct |
Footnotes
F1: In connection with the appointment of Dr. Flammer as the Company's Chief Medical Officer, the Company granted Dr. Flammer an option to purchase a total of 150,990 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Flammer's continued employment with the Company on each vesting date.